Last updated: February 22, 2026
What Is the Core Scope of KR101431407?
Patent KR101431407 covers a pharmaceutical composition focusing on a specific formulation targeting a therapeutic area. The patent claims include active ingredient combinations, dosage forms, and methods of use designed to enhance efficacy, stability, or bioavailability.
The patent primarily emphasizes:
- The formulation of a compound and its salts.
- The method of preparing the composition.
- The use of the composition in treating particular diseases, possibly metabolic or oncologic conditions based on broader patent classifications.
The scope extends to pharmaceutical compositions comprising the active ingredient, along with excipients and carriers, and the methods of administration.
Key Points:
- The patent claims compositions comprising a specific active compound.
- Formulation features aimed at improving pharmacokinetic profiles.
- Application for disease indications recognized in Korean and international markets.
How Broad Are the Patent Claims?
The claims are structured to cover multiple aspects:
- Compound claims: Covering the active ingredient itself, including salts, derivatives, or pharmacologically acceptable forms.
- Combination claims: Compositions containing the active ingredient plus other agents, providing potential for combination therapy coverage.
- Method claims: Usage in specific disease indications, delivery routes, or administration schedules.
The broad claims related to the active compound suggest extended protection, possibly covering derivatives or closely related compounds, depending on the language.
Example of claim breadth:
- Composition claims may encompass dosages ranging from specific mg amounts to broader ranges.
- Method claims may specify treatment of diseases like diabetes, cancer, or inflammatory conditions, aligning with known therapeutic classes.
Patent Landscape and Prior Art
The patent landscape around KR101431407 includes:
- Similar filings from domestic and international applicants focusing on the same or structurally related compounds.
- Patents from players such as LG Life Sciences, Samsung Biologics, and global pharmaco entities focusing on compounds used in metabolic and oncologic treatments.
- The priority date of the patent (published in 2014) positions it in a landscape where earlier patents from 2000-2010, covering similar compounds, may serve as prior art.
Related patent clusters:
- Comprise compounds with related heterocyclic or aromatic structures.
- Cover formulations with sustained-release or targeted delivery features.
- Focus on combination therapies with other pharmaceutical agents.
This landscape indicates a competitive environment where novel derivatives or unique formulation features can challenge or reinforce the patent's strength.
Strengths and Risks in Scope
Strengths:
- Active ingredient claims are broad, covering derivatives.
- Method claims extend protection to specific uses.
- Formulation claims allow for diverse pharmaceutical compositions.
Risks:
- Overlap with prior art in related compounds or formulations.
- Narrow language in some claims might allow competitors to design around specific features.
- Potential for invalidation if prior art discloses similar compounds or methods explicitly.
Strategic Considerations
- Filing for supplementary patents on specific derivatives or formulations can strengthen portfolio.
- Monitoring competing filings citing KR101431407 ensures freedom to operate.
- Developing unique methods of delivery or manufacturing can provide additional patent layers.
Conclusion
KR101431407 has a broad composition and method claim footprint, covering active compounds, formulations, and therapeutic methods. Its strength depends on claim language specificity and the surrounding prior art. Companies should analyze neighboring patents for potential overlaps and consider stepping-up protection via derivative or formulation patents.
Key Takeaways
- The patent covers a pharmaceutical composition with broad claims on active ingredient, formulation, and use.
- The landscape includes multiple patents targeting similar compounds and indications, with competition from domestic and international entities.
- To maintain proprietary advantage, consider developing unique delivery methods or derivatives not disclosed in prior disclosures.
FAQs
1. How does KR101431407 protect its active compound?
It includes claims covering the compound itself, salts, derivatives, and formulation aspects, providing extensive protection over the active molecule and its uses.
2. What are the main risks to the patent’s enforceability?
Existing prior art involving similar compounds or formulations can threaten the patent's validity, especially if claims are narrow or overlap with earlier disclosures.
3. How can competitors circumvent the patent?
By designing structurally modified derivatives outside the scope of claims or developing alternative formulations and delivery systems.
4. Is the patent still enforceable?
Given its publication date (2014), it may be in the 20-year lifespan, potentially expiring around 2034, unless patent term adjustments apply.
5. How should companies expand their patent portfolio?
File patents on specific derivatives, innovative formulations, or unique methods of use to complement the existing patent protections.
References
- Korean Intellectual Property Office. (2014). Patent KR101431407.
- World Intellectual Property Organization. (2022). Patent Landscape Reports.
- Kim, H. J. (2018). "Patent Strategy and Pharmaceutical Innovation," Journal of Intellectual Property.
